The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. Edibles won’t produce the same experience, but topicals may be able to help, too.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

OCTOBER 2, 2022

The best type of cannabis to treat nausea is a Type I or Type II strain with a terpene profile that includes limonene or humulene. Strain names are an unreliable indicator of experience, so the ones included in this article should serve as a starting point to finding flower with a similar chemical makeup. CBDA and nausea.

Terpenes 113

Terpenes Strains THC Oil 113

Greencamp

MAY 1, 2019

Marijuana for nausea became FDA approved and available for medicinal use in 1985 in the US, and Canada legalized it for these purposes back in 2001. One of the first studies on this topic was published in 1975, when a group of researchers looked deep into THC’s antiemetic effects in 20 cancer patients receiving chemotherapy. (

Patients 89

Patients Strains Sativa Marijuana 89

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. However, to access cannabis patients would have to seek medical advice from a doctor who would then prescribe them cannabis based upon their needs, discussing topics such as THC content and frequency of use.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Puff Puff Post

SEPTEMBER 24, 2019

On July 30 th , 2001, the government brought this into a legislative act known as the Medical Marijuana Access and Resources (MMAR). The human body showed significant evidence of harboring specific receptors, aptly known as cannabinoid receptors. In the ECS, the “keys” are referred to as endogenous cannabinoids. .

History 94

History Cannabinoids Indica Tincture 94

Puff Puff Post

JUNE 5, 2019

This brought the legislative act known as the Medical Marijuana Access and Resources (MMAR) into legislature on July 30 th , 2001 permitted patients access to cannabis for medicinal purposes, from Licensed Producers approved by Health Canada. The brain produces endogenous cannabinoids, referred to as endocannabinoids.

Medicine 96

Medicine Patients Cannabinoids Oil 96

CannaTech

SEPTEMBER 16, 2018

Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. Many healthcare practitioners possess a knowledge gap about cannabis, as their medical school curriculum didn’t include any information on the topic. Changing Cannabis Conversations Worldwide.

Education 66

Education Medicine Clinical Trials Patients 66